InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,419.20
(
0.00%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.45
(
0.38%
)
Bitcoin
64,471.10
(
0.74%
)

Replies to post #1619 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1619 on Enanta Pharmaceuticals Inc (ENTA)

DewDiligence

04/26/18 9:12 AM

#1620 RE: DewDiligence #1619

ABBV raises 2018 HCV sales guidance to $3.5B (from $2.5B). Almost all of this will come from Mavyret (which accounted for $850M of the $919M HCV sales logged during 1Q18).